Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers

John Radford

doi:10.1200/JCO.23.02763

Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	1868-1870
Number of pages	3
Journal	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume	42
Issue number	16
Early online date	13 Mar 2024
DOIs	https://doi.org/10.1200/JCO.23.02763
Publication status	Published - 1 Jun 2024

Keywords

Antibiotics, Antineoplastic/adverse effects
Breast Neoplasms/drug therapy
Doxorubicin/adverse effects
Female
Follow-Up Studies
Humans

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.23.02763

Cite this

@article{9824736da30540dca07dc67f1dbe704d,

title = "Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers",

keywords = "Antibiotics, Antineoplastic/adverse effects, Breast Neoplasms/drug therapy, Doxorubicin/adverse effects, Female, Follow-Up Studies, Humans",

author = "John Radford",

year = "2024",

month = jun,

day = "1",

doi = "10.1200/JCO.23.02763",

language = "English",

volume = "42",

pages = "1868--1870",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "16",

}

TY - JOUR

T1 - Doxorubicin and Breast Cancer Risk

T2 - The Importance of Long-Term Follow-Up in Curable Cancers

AU - Radford, John

PY - 2024/6/1

Y1 - 2024/6/1

KW - Antibiotics, Antineoplastic/adverse effects

KW - Breast Neoplasms/drug therapy

KW - Doxorubicin/adverse effects

KW - Female

KW - Follow-Up Studies

KW - Humans

UR - http://www.scopus.com/inward/record.url?scp=85194937257&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/8e6b6a34-5256-31d5-8a6e-b75f6078f785/

U2 - 10.1200/JCO.23.02763

DO - 10.1200/JCO.23.02763

M3 - Editorial

C2 - 38478798

SN - 0732-183X

VL - 42

SP - 1868

EP - 1870

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

IS - 16

ER -

Doxorubicin and Breast Cancer Risk: The Importance of Long-Term Follow-Up in Curable Cancers

Keywords

UN SDGs

Access to Document

Other files and links

Cite this